BioStable logo — Advancing cardiovascular health with innovative, cost-effect...

BioStable

Advancing cardiovascular health with innovative, cost-effective medical devices that enhance patient outcomes.

Founded 2008 Series C Total: $10.75M Biotechnology, Health Care +1

General Information

Company Name BioStable
Founded Year 2008
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with BioStable. To contact BioStable, visit biostable-s-e.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioStable compare?

A PDF of BioStable and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioStable soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioStable

BioStable is a cardiovascular device company focused on developing innovative treatments for cardiovascular diseases. Led by a team of seasoned industry executives, BioStable leverages its expertise in rapid and effective medical device development, covering all facets of product development, including quality systems, design, engineering, prototyping, testing, manufacturing, regulatory relationships, clinical validation, market launch, and distribution. The company specializes in minimizing time to market for cost-effective medical devices that enhance clinical outcomes. Founded in 2008, BioStable's key focus is on developing and commercializing proprietary valve repair technologies, which provide an alternative to valve replacement for patients with aortic valve disease. In its Series C investment at 25 February 2020, BioStable attracted funding from Santé Ventures, Rex Health Ventures, Solas BioVentures, Longmeadow Capital, and Orlando Health Ventures. This diverse investor group reflects the industry's confidence in BioStable's potential to address critical cardiovascular health needs.

Business keywords: cardiovascular device company, medical device development, valve repair technologies, aortic valve disease, innovative treatments, cost-effective, clinical outcomes, R&D, rapid product development, regulatory relationships, market launch, quality systems, patient outcomes, prototyping

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Undisclosed 5
Santé Ventures, Rex Health Ventures +3
25 Feb 2020
Series B $4.25M 1
Santé Ventures
29 Apr 2015
Series A $6.25M 1
Santé Ventures
15 Dec 2008
Venture Round $250.00K -
22 Aug 2008

BioStable Alternatives & Competitors

View All Alternatives
BioStable vs
Novostia
Novostia Switzerland

Heart valves for life, for patients of any age, including children

15 employees
Health Care, Medical Devices
BioStable vs

Advancing minimally invasive image-guidance technologies for medical procedures around the world

Venture round
68 employees
Health Care, Medical Devices
BioStable vs

Your strategic partner in advancing patient health

Private Equity
81 employees
Biotechnology, Health Care

FAQ About BioStable

Advancing cardiovascular health with innovative, cost-effective medical devices that enhance patient outcomes.
BioStable was founded in 2008.
BioStable operates in Biotechnology, Health Care and Medical Devices. Its work centres on cardiovascular device company, medical device development, valve repair technologies and aortic valve disease.
BioStable has completed 4 funding rounds, raising a total of $10.75M. The latest funding stage is Series C.
Top alternatives and competitors to BioStable include Novostia, Conavi Medical, TMC Pharma Services Ltd, Sonosemi Medical, Affluent Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioStable and Novostia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioStable, https://bouncewatch.com/company/biostable, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes